Prof. Gabi Barbash, a top commentator on matters related to the coronavirus since the pandemic began, assesses that US President Donald Trump’s doctors apparently have managed to prevent him from suffering a serious illness.
Prof. Gabi Barbash, former director general at Tel Aviv Sourasky Medical Center, on April 7, 2020. (Channel 12)
Speaking on Channel 12, Barbash explains that of the two drugs Trump was given, remdesivir prevents the virus from replicating in the body while Regeneron is experimental and includes antibodies that destroy the virus. Regeneron has been used on 270 patients so far with no side effects, he says.
“I imagine that his doctors assessed that he was on the path to serious illness, judging by the first two days,” Barbash says. “They took a make-or-break decision to give him experimental treatment. They apparently gave it to him very early. The effect of the antibodies given early in the illness… was apparently effective. Now they’re using steroids to prevent complications of the immune system.”
Asked whether Trump is out of danger if they discharge him tomorrow, Barbash says: “He’s not without danger, but, overall, they’ve apparently taken him out of the early stage of what could have been serious illness.”
Animal lovers, this one's for you
In 1935, Rabbi Max Shorenstein left Denmark to pursue his lifelong dream: building a zoo in Tel Aviv and teaching children to love animals. The Tel Aviv Zoo became one of the city’s greatest attractions, but envy, greed, and corruption drove Shorenstein from the paradise he created.
The film 'There Are No Lions in Tel Aviv' is available to screen November 19-26 for members of our reader support group, The Times of Israel Community. Join the Community todayto support our work and watch our DocuNation series of outstanding Israeli documentary films.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel